Alume Biosciences

Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertent injury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.

Domain

alumebiosciences.com

Employees

11-50

Last Funding

$6.0M

Founded

2016

Frequently Asked Questions

What technologies does Alume Biosciences use?+

Alume Biosciences uses 12 technologies including WordPress, Google Code Prettify, Bootstrap.

What industry is Alume Biosciences in?+

Alume Biosciences operates in the Biotechnology industry.

Where is Alume Biosciences based?+

Alume Biosciences is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026